Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Avalon GloboCare Corp. (AVCO)
|
Add to portfolio |
|
|
|
| Price: |
$0.82
| | Metrics |
| OS: |
10.8
|
M
| |
|
|
| Market cap: |
$8.87
|
M
| |
|
|
|
Net debt:
|
$7.6
|
M
| |
|
|
|
EV:
|
$16.5
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($6.2)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 1.4 | 1.4 | 1.5 | 1.6 | 1.1 | 0.6 | 0.0 | 0.0 |
| Revenue growth | 1.0% | -10.9% | -1.0% | 45.0% | 74.8% | | | |
| Cost of goods sold | 1.0 | 1.0 | 1.2 | 1.2 | 1.1 | 0.1 | 0.0 | 0.0 |
| Gross profit | 0.4 | 0.4 | 0.3 | 0.4 | 0.0 | 0.5 | 0.0 | 0.0 |
| Gross margin | 29.8% | 28.3% | 22.0% | 24.8% | -4.6% | 88.1% | | |
| Sales and marketing | | | | | 0.0 | 0.0 | | |
| Research and development | 1.0 | 0.9 | 1.8 | 0.0 | | | | |
| General and administrative | 8.2 | 12.0 | 16.9 | 8.0 | 2.8 | 0.4 | 0.0 | 0.0 |
| EBITA | -8.8 | -11.5 | -19.4 | -7.4 | -2.6 | 0.1 | 0.0 | 0.0 |
| EBITA margin | -630.7% | -834.9% | -1256.7% | -470.9% | -237.3% | 12.5% | | |
| Amortization of intangibles | | | | 0.3 | | | | |
| EBIT | -8.8 | -11.5 | -19.4 | -7.7 | -2.6 | 0.1 | 0.0 | 0.0 |
| EBIT margin | -630.7% | -834.9% | -1256.7% | -491.9% | -237.3% | 12.5% | | |
| Pre-tax income | -9.1 | -12.7 | -18.1 | -8.1 | -4.0 | 0.1 | 0.0 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 28.3% | 0.0% | 0.0% |
| Net income | -9.1 | -12.7 | -18.1 | -7.8 | -3.5 | 0.1 | 0.0 | 0.0 |
| Net margin | -653.5% | -920.3% | -1168.6% | -497.6% | -321.5% | 9.0% | | |
| |
| Diluted EPS | ($0.11) | ($0.16) | ($0.24) | ($0.11) | ($0.05) | $0.00 | $0.00 | $0.00 |
| Shares outstanding (diluted) | 84.9 | 79.5 | 75.1 | 72.0 | 65.0 | 51.1 | 6.3 | 6.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|